Dr. Matthew Jude Schnellbaecher, MD

Dr. Schnellbaecher practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Schnellbaecher's NPI, 1942233481, was assigned on July 8, 2006. Dr. Schnellbaecher graduated from Columbia University College of Physicians and Surgeons in 1989. Dr. Schnellbaecher holds Alaska license 3722.

Dr. Schnellbaecher's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Schnellbaecher's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. Dr. Schnellbaecher is also affiliated with Providence Alaska Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Schnellbaecher to 3 more hospitals and 3 medical groups, each named with a free account. Dr. Schnellbaecher's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schnellbaecher practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schnellbaecher's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schnellbaecher is licensed in Alaska.

CMS data shows 1,412 Medicare services from Dr. Schnellbaecher across 14 procedure codes in 2024, for 924 Medicare patients. Medicare paid $81,618 for them.

CMS counts 924 Medicare patients who saw Dr. Schnellbaecher in 2024. The largest group is 65 to 74, with 467 patients. 75% of them have high blood pressure, and 57% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schnellbaecher's median patient age at 76, with 40% women.

In 2024, Dr. Schnellbaecher wrote 1,186 Medicare Part D claims for 163 patients. 88% of them were for generic drugs. CMS names the drug for 1,029 of them, across 22 drugs with 11 or more claims each, at $76,868 in total drug cost. In 2023, CMS named 1,006 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Schnellbaecher for performance year 2024, reported as part of a group. Dr. Schnellbaecher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schnellbaecher as offering telehealth.

CMS Open Payments shows 37 general payments to Dr. Schnellbaecher from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Medtronic, Inc. paid the most, $288.

Dr. Schnellbaecher graduated from Columbia University College of Physicians and Surgeons in 1989.